STOCK TITAN

INUV (NYSE American: INUV) suspends ATM program, ends continuous offering

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
424B5

Rhea-AI Filing Summary

INUV suspends its at-the-market (ATM) offering and terminates continuous sales effective June 30, 2026. The prospectus supplement states the company may offer and sell common stock having an aggregate offering price of up to $15,000,000 under the Offering Agreement with H.C. Wainwright.

The supplement reports the company has sold 165,641 shares through the sales agent, generating $1,184,740 in gross proceeds to date. The supplement also states the last reported sale price was $1.36 per share on June 29, 2026. The Offering Agreement remains in full force and effect, but no sales will occur under it unless a new prospectus supplement is filed.

Positive

  • None.

Negative

  • None.

Insights

Neutral administrative pause of the ATM program with quantified remaining capacity.

The supplement formally suspends at‑the‑market sales effective June 30, 2026 while retaining the Offering Agreement. It restates the registered capacity of $15,000,000 aggregate offering price and reports prior sales of 165,641 shares for $1,184,740 gross proceeds.

Practical dependencies include whether the company files a replacement prospectus supplement to resume sales and any market conditions affecting execution; cash‑flow treatment and specific use of proceeds are not detailed in the excerpt.

Registered ATM capacity $15,000,000 aggregate offering price under the Offering Agreement
Shares sold to date 165,641 shares sold through Wainwright under the Offering Agreement
Gross proceeds to date $1,184,740 gross proceeds from shares sold under the Offering Agreement
Last reported sale price $1.36 last reported NYSE American sale price on June 29, 2026
Effective suspension date June 30, 2026 termination of continuous offering per prospectus supplement
At the Market Offering Agreement regulatory
"may offer and sell shares of our common stock from time to time pursuant to the terms of an At the Market Offering Agreement"
An at-the-market offering agreement is a contract that lets a company sell newly issued shares directly into the open market through a broker, at whatever price the stock is trading at that moment. For investors this matters because it can increase the number of shares available (which may dilute existing ownership) while providing a flexible, often faster way for the company to raise cash without fixing a price, similar to a vendor selling small batches at current market stalls rather than setting a single fixed price.
Prospectus Supplement regulatory
"This prospectus supplement amends and supplements the information in our prospectus"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
aggregate offering price financial
"may offer and sell shares of our common stock having an aggregate offering price of up to $15,000,000"
The aggregate offering price is the total dollar amount that will be raised if all the securities in an offering are sold at the stated offering price, before fees or expenses are taken out. Investors use it to gauge the size of the fundraising and its potential effects—such as how much cash the company will get and how much existing ownership might be reduced—similar to totaling every item’s price in a shopping cart to see the full bill.
Offering Type ATM
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(5)

Registration No. 333-277878

 

PROSPECTUS SUPPLEMENT

(To the Prospectus Supplement Dated May 7, 2024 and

Prospectus dated May 1, 2024)

 

 

Inuvo, Inc.

 

This prospectus supplement amends and supplements the information in our prospectus dated May 1, 2024, as previously supplemented by the prospectus supplement dated May 7, 2024, which form a part of our Registration Statement on Form S-3 (File No. 333-277878), or the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus and is qualified in its entirety by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prospectus supplemented. This prospectus supplement is not complete without, and may only be delivered or utilized in connection with, the Prospectus and any future amendments or supplements thereto.

 

We filed the Prospectus to register the offer and sale of shares of our common stock from time to time pursuant to the terms of an At the Market Offering Agreement, dated May 7, 2024, or the Offering Agreement, that we entered into H.C. Wainwright & Co., LLC, or Wainwright, as our sales agent thereunder. As of the date of this prospectus supplement, we have sold 165,641 shares of our common stock through Wainwright under the Offering Agreement totaling $1,184,740 million in gross proceeds. Without giving effect to any offering limit imposed by General Instruction I.B.6 of Form S-3, we may offer and sell shares of our common stock having an aggregate offering price of up to $15,000,000 from time to time through Wainwright acting as our sales agent in accordance with the terms of the Offering Agreement.

 

The purpose of this prospectus supplement is to suspend the Offering Agreement and to terminate the continuous offering by us under the Prospectus effective June 30, 2026. We will not make any sales of our common stock pursuant to the Offering Agreement unless and until a new prospectus supplement is filed with the Securities and Exchange Commission; however, the Offering Agreement remains in full force and effect.

 

Our common stock is listed on NYSE American under the symbol “INUV.” On June 29, 2026, the last reported sale price of our common stock on NYSE American was $1.36 per share.

 

The date of this prospectus supplement is June 30, 2026

 

FAQ

What action did INUV take regarding its ATM offering?

INUV suspended the ATM offering and terminated continuous sales effective June 30, 2026. The prospectus supplement states the Offering Agreement remains in force but no sales will occur under it unless a new prospectus supplement is filed.

How much capacity remains under INUV's registered ATM program?

The supplement restates an aggregate offering capacity of $15,000,000. The prospectus supplement says the company may offer and sell shares having an aggregate offering price of up to $15,000,000 through the sales agent under the Offering Agreement.

How many shares has INUV sold under the Offering Agreement to date?

The supplement reports 165,641 shares sold through the sales agent. Those sales generated $1,184,740 in gross proceeds, according to the prospectus supplement’s disclosure of prior activity under the program.

Will INUV continue selling shares under the Offering Agreement now?

No sales will be made under the Offering Agreement unless a new prospectus supplement is filed. The supplement states the company suspended the Offering Agreement’s continuous offering effective June 30, 2026, while the agreement itself remains in full force.

What was INUV's last reported share price cited in the supplement?

The last reported sale price was $1.36 per share on June 29, 2026. The supplement cites the NYSE American last sale price as $1.36 per share on June 29, 2026.